ÃÒ§ҹ¡ÒûÃЪØÁ¤³Ð¡ÃÃÁ¡ÒÃÍӹǡÒäسÀÒ¾ (QST) ¤ÃÑé§·Õè 6/2561

Çѹ¾ÄËÑʺ´Õ·Õè 9 ÊÔ§ËÒ¤Á 2561

³ Ëéͧ»ÃЪØÁÊÁªÒ ÊÁºÙóìà¨ÃÔ­ ªÑé¹ 5 ʶҺѹÁÐàÃç§áË觪ҵÔ

¼ÙéÁÒ»ÃЪØÁ

1.      ¹ÒÂá¾·ÂìÇÕÃÇØ²Ô

ÍÔèÁÊÓÃÒ­

¼ÙéÍӹǡÒÃʶҺѹÁÐàÃç§áË觪ҵÔ

»Ãиҹ¡ÃÃÁ¡ÒÃ

2.     ¾Ç.ÍÅÔÊÒ

ªèǧÍÃØ³

ÃÑ¡ÉÒ¡ÒÃÃͧ¼ÙéÍӹǡÒôéÒ¹¡ÒþÂÒºÒÅ»Ãиҹ·ÕÁͧ¤ì¡Ã¾ÂÒºÒÅ (NSO)

¡ÃÃÁ¡ÒÃ

3.     ¹ÒÂÊÁÈÑ¡´Ôì

ǧÈÒ¹ÃÒ¸Ôº

Ãͧ¼ÙéÍӹǡÒôéÒ¹ÍӹǡÒÃ

»Ãиҹ·ÕÁ¡ÒèѴ¡ÒÃà¤Ã×èͧÁ×Í (EQ) ¤³Ð¡ÃÃÁ¡ÒÃÃѺàÃ×èͧÃéͧàÃÕ¹

¡ÃÃÁ¡ÒÃ

4.     ¹ÒÂá¾·ÂìÊÁªÒÂ

¸¹ÐÊÔ·¸ÔªÑÂ

¼ÙéªèǼÙéÍӹǡÒôéÒ¹¾Ñ²¹Ò¤Ø³ÀÒ¾âç¾ÂÒºÒÅ, ËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÇÔ¨ÑÂ, ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹¾Ñ²¹Ò¤Ø³ÀÒ¾

»Ãиҹ·ÕÁºÃÔËÒäÇÒÁàÊÕè§ (RM),

PCT à¤ÁպӺѴ áÅзÕÁͧ¤ì¡Ãá¾·Âì (MSO)

¡ÃÃÁ¡ÒÃ

5.     ¹Ò§ÈÔÃÔ¾Ãó

¾ÔÉÒÀÒ¾

¼ÙéªèǼÙéÍӹǡÒôéÒ¹¡Ô¨¡ÃÃÁ¾ÔàÈÉ

ËÑÇ˹éÒ½èÒºÃÔËÒ÷ÑèÇä»

¡ÃÃÁ¡ÒÃ

6.     ¹ÒÂá¾·Âì»ÔÂÇѲ¹ì

àÅÒÇËØµÒ¹¹·ì

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÁÐàÃç§¹ÃÕàǪ

»Ãиҹ·ÕÁ¾Ñ²¹Ò¤Ø³ÀÒ¾¼Ùé»èǹ͡

¡ÃÃÁ¡ÒÃ

7.     ¹ÒÂá¾·ÂìâÊÌÊ

͹ت»ÃÕ´Ò

ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÍÒÂØÃÈÒʵÃì

»Ãиҹ·ÕÁ»éͧ¡Ñ¹áÅФǺ¤ØÁ¡ÒõԴàª×éÍ

¡ÃÃÁ¡ÒÃ

8.     ¹ÒÂá¾·Âì´¹ÑÂ

Áâ¹ÃÁ³ì

ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹Ê¹ÑºÊ¹Ø¹ÇÔªÒ¡ÒÃ

»Ãиҹ·ÕÁ PCT ÈÑÅ¡ÃÃÁ

¡ÃÃÁ¡ÒÃ

9.     ¹ÒÂá¾·Âì¾ÕÃÇÔª­ì

·Ñ¾Ç§Éì

ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÃѧÊÕÃÑ¡ÉÒ

»Ãиҹ·ÕÁ PCT ÃѧÊÕÃÑ¡ÉÒ

¡ÃÃÁ¡ÒÃ

10.  ¹ÒÂá¾·Âì¨ØÁ¾Å

ÊÔ§ËìËÔÃÑ­¹ØÊóì

ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹¾Ñ²¹Ò¹âºÒÂáÅÐÂØ·¸ÈÒʵÃì¡ÒÃá¾·Âì áÅлÃиҹ·ÕÁºÃÔËÒÃáÅоѲ¹Ò·ÃѾÂҡúؤ¤Å (HRD)

¡ÃÃÁ¡ÒÃ

11.  À­.ÇÃÑ­­Ò

¤Ãͧá¡éÇ

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹àÀÊѪ¡ÃÃÁ

àŢҹءÒ÷ÕÁ¾Ñ²¹ÒÃкºÂÒ (PTC)

¡ÃÃÁ¡ÒÃ

12.  ¾Ç.¾ÑªÃÕ 

à¨ÃÔ­¾Ã    

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹¡ÒþÂÒºÒżÙé»èǹ͡

¡ÃÃÁ¡ÒÃ

13.  ¾Ç.¡Ãª®Ò

ÅÕÅÒàÅÔÈ»ÃÐàÊÃÔ°

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹¡ÒþÂÒºÒżÙé»èÇÂã¹

àŢҹءÒ÷ÕÁ¡ÒèѴ¡ÒÃà¤Ã×èͧÁ×Í (EQ)

¡ÃÃÁ¡ÒÃ

14.  ¾Ç.ÍÃÊÒ

ÍѤÃÇѪÃÒ§¡ÙÃ

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÇÔªÒ¡ÒþÂÒºÒÅ

¡ÃÃÁ¡ÒÃ

15.  ¹Ò§ÍÒÃÕÂì

»ÃÐÊÔ·¸Ô¾Â§¤ì

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹à·¤¹Ô¤¡ÒÃá¾·Âì

¡ÃÃÁ¡ÒÃ

16.  ¹Ò§Ãѵ¹Ò

à¿×èͧ·ÃѾÂì

ËÑÇ˹éÒ½èÒ¾ÑÊ´ØáÅкÓÃØ§ÃÑ¡ÉÒ

¡ÃÃÁ¡ÒÃ

17.  ¹ÒÂ⪤ªÑÂ

ÊØ¢àËÅ×ͧ

ËÑÇ˹éÒ½èÒÂá¼¹§Ò¹áÅлÃÐàÁÔ¹¼Å

¡ÃÃÁ¡ÒÃ

18.  ¹Ò§¾ÔÁ¾ìÇÕÃÒ

ªÙ·Ç´       

ËÑÇ˹éÒ½èÒÂÊÇÑÊ´Ô¡ÒÃÊѧ¤ÁáÅлÃÐ¡Ñ¹ÊØ¢ÀÒ¾, àŢҹءÒä³Ð¡ÃÃÁ¡ÒÃÃѺàÃ×èͧÃéͧàÃÕ¹

¡ÃÃÁ¡ÒÃ

19.  ¹Ò§ÊÒǼ¡Ò¡ÁÅ

¨Ñ¹·ÃìÊØ¾Ã»ÃÐÀÒ

ËÑÇ˹éÒ½èÒ·ÃѾÂҡúؤ¤Å, àŢҹءÒ÷ÕÁºÃÔËÒÃáÅоѲ¹Ò·ÃѾÂҡúؤ¤Å (HRD)

¡ÃÃÁ¡ÒÃ

 

¼ÙéäÁèÁÒ»ÃЪØÁ

1.     ¹ÒÂá¾·ÂìÍÒ¤Á

ªÑÂÇÕÃÐÇѲ¹Ð

Ãͧ¼ÙéÍӹǡÒôéÒ¹¡ÒÃá¾·Âì

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹à·¤â¹âÅÂÕáÅÐÊÒÃʹà·È

Ãͧ»Ãиҹ

(µÔ´ÃÒª¡ÒÃ)

2.     ¹Ò§ÊÒÇÈØÅÕ¾Ã

áʧ¡ÃШèÒ§

Ãͧ¼ÙéÍӹǡÒôéÒ¹¾Ñ²¹ÒÃкºÊØ¢ÀÒ¾

»Ãиҹ¤³Ð¡ÃÃÁ¡ÒèѴ¡ÒäÇÒÁÃÙé (KM)

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

3.     ¹ÒÂá¾·ÂìÀÙÇÈÔɰì

ÇÃÒÃѰàÃ×Í§ÇØ²Ô

¼ÙéªèǼÙéÍӹǡÒôéÒ¹¡ÒÃà§Ô¹

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÃѧÊÕÃÑ¡ÉÒ

»Ãиҹ·ÕÁàǪÊÒÃʹà·È (IM)

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

4.     ¹Ò¹ÃÔ¹·Ãì

à¨É®ÒÀÙÃÔ

¼ÙéªèǼÙéÍӹǡÒôéÒ¹Ê×èÍÊÒÃͧ¤ì¡Ã

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

5.      ¹ÒÂá¾·ÂìÃÐÇÔÈÑ¡´Ôì

¨Ñ¹·ÃìÇÒʹì

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÈÑÅÂÈÒʵÃì

»Ãиҹ·ÕÁ ECT Hepatopancreatobilliary

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

6.      á¾·ÂìË­Ô§ÍêÃ

àÍÕèÂÁÍÒÃÕÃѵ¹ì             

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹ÇÔÊÑ­­ÕÇÔ·ÂÒ

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

7.      á¾·ÂìË­Ô§¡¹¡¾Ã

ã¨Ê¶Ò¾Ã

ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹à¤ÁպӺѴ

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

8.      ¹ÒÂá¾·ÂìàÍ¡À¾

áʧÍÃÔÂǹԪ

ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹âʵ ÈÍ ¹ÒÊÔ¡

»Ãиҹ·ÕÁ ECT Head and Neck,  ·ÕÁ¾Ñ²¹ÒÃкºàǪÃÐàºÕ¹áÅÐàÍ¡ÊÒÃÏ

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

9.      á¾·ÂìË­Ô§ÈÃÒÇÃó

ºØ­ÅÔ¢Ôµ

á.¡ÅØèÁ§Ò¹ÃѧÊÕÇÔ¹Ô¨©ÑÂáÅÐàǪÈÒʵÃì¹ÔÇà¤ÅÕÂÃì

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

10.   á¾·ÂìË­Ô§³ÑɰÒ

¾ÔÀ¾äªÂÒÊÔ·¸Ôì

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹âÀª¹ÈÒʵÃì

»Ãиҹ·ÕÁ ECT Lung

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

11.   ¹ÒÂá¾·ÂìþվѲ¹ì

¶¹ÍÁà¾çªÃʧèÒ

ÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹àǪÈÒʵÃì»ÃФѺ»ÃФͧ

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

12.   ·Ñ¹µá¾·ÂìË­Ô§¡Ñ·ÅÕ

¡ÔµµÔ»ÃÐÊÒÃ

ËÑÇ˹éÒ¡ÅØèÁ§Ò¹·Ñ¹µ¡ÃÃÁ

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

13.   ¹Ò§ÊÒÇÇÃÒÃѵ¹ì

¡Ñ¹ÍÃØ³ÀÙÇÔÊÔ°

ËÑÇ˹éÒ½èÒ¡ÒÃà§Ô¹áÅкѭªÕ

¡ÃÃÁ¡Òà (µÔ´ÃÒª¡ÒÃ)

 

¼Ùéà¢éÒÃèÇÁ»ÃЪØÁ

 1.á¾·ÂìË­Ô§ÇÔÀÒÇÕ

ÊÃþÊÔ·¸ÔìǧÈì

»Ãиҹ·ÕÁ PCT Palliative care áÅзÕÁ HPH

 2.á¾·ÂìË­Ô§ª­Ò¹Ôɰì

ÈÔÃÔäÊÂ

Ãͧ»Ãиҹ·ÕÁ ECT Gastrointestinal

 3.¹ÒÂá¾·ÂìÈØÀÇѲ¹ì

ÈÔÃԤػµì

»Ãиҹ·ÕÁ ECT Uro

 4.¹ÒÂ͹ؾ§Éì

äªÂÁÙÅ

»Ãиҹ·ÕÁ¾Ñ²¹Ò¤Ø³ÀÒ¾ÊÔè§áÇ´ÅéÍÁ (ENV)

 5.¾Ç.¡Ñ³±ÇÃó

ªØèÁàª×éÍ

àŢҹءÒ÷ÕÁ¾Ñ²¹Ò¤Ø³ÀÒ¾¼Ùé»èǹ͡ (SLT OPD)

 6.¾Ç.¨ÃÔÂÒ

ʧǹä·Ã

àŢҹءÒ÷ÕÁ PCT ÃѧÊÕÃÑ¡ÉÒ

ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅÃѧÊÕÃÐÂÐä¡Å

 7.¾Ç.ÇÔÅÒÇÑÅÂì

àÅéÒÊ¡ØÅ

àŢҹءÒ÷ÕÁ PCT à¤ÁպӺѴ

ËÑÇ˹éÒ¾ÂÒºÒÅÈÙ¹ÂìºÃÔËÒÃÂÒà¤ÁպӺѴ¼Ùé»èǹ͡

      8.     ¾Ç.ºØ»¼ÒªÒµÔ

¢Ø¹ÍÔ¹·Ãì

àŢҹءÒ÷ÕÁ ECT Breast

      9.     ¾Ç.͹ѹ·ÔÂÒ

¾ØèÁà¾çªÃ

àŢҹءÒ÷ÕÁ ECT Gynae

   10.¾Ç.ÊØÀÕ

·Í§»Ò¹

àŢҹءÒ÷ÕÁ ECT Head and Neck

   11.¾Ç.ÊÁÈÃÕ

»ÃÐʺ⪤

àŢҹءÒ÷ÕÁ ECT Lung

   12.¾Ç.ÈØÀÒÃÁÂì

ÈÃըѹ·Ãì´Õ

àŢҹءÒ÷ÕÁ ECT Gastrointestinal

   13.¾Ç.¾Ã¨Ñ¹·Ãì

ÊÑÂÅÐÁÑÂ

àŢҹءÒ÷ÕÁ ECT Hepatopancreatobilliary

   14.¾Ç.ä¡ÃÃÇÕ

»ÃÐÀÒ¡Ã

àŢҹءÒ÷ÕÁ»éͧ¡Ñ¹áÅФǺ¤ØÁ¡ÒõԴàª×éÍ (IC)

   15.¾Ç.ÀÑ·ÃÒ¾Ã

ÀÑ·ÃÇÅÕ

àŢҹءÒ÷ÕÁºÃÔËÒäÇÒÁàÊÕè§ (RM)

   16.¹Ò§¨ÔÃѹ´Ò

ä¡ÃÄ·¸ÔªÑÂ

àŢҹءÒ÷ÕÁÊÃéÒ§àÊÃÔÁÊØ¢ÀÒ¾áÅÐÍÒªÕÇ͹ÒÁÑ (HPH), KM

   17.¹Ò§ÊÒǨÃÔÂÒ

Á³Õà·¾

àŢҹءÒ÷ÕÁàǪÊÒÃʹà·È (IM)

   18.¾Ç.¹Ñ¹·ÂÒ

¤³Ò

ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅËͼÙé»èǾÔàÈÉ ªÑé¹ 8

   19.     ¾Ç.»ÃÒö¹Ò

¤ÓÁÒµÃ

ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅËͼÙé»èǪҠªÑé¹ 7

 

   20.     ¾Ç.ÈØÀÃÑ¡Éì

á¹ÇǧÈì

ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅËͼÙé»èÇÂÁÐàÃç§ÊµÃÕ ªÑé¹ 6

 

   21.     ¾Ç.ÃѪ´ÒÀÒ

ÊÕ´Ò´ÒÉ

ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅËͼÙé»èÇÂà¤ÁպӺѴ ªÑé¹ 5

 

   22.     ¾Ç.¾ÃóÒÃÕ

ÃØ¨Ô¡Ñ³ËÐ

ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅËͼÙé»èÇÂ˹ѡ

 

   23.     ¾Ç.ÊØ¹ÕÂì

¿Ñ¡¹éÍÂ

á·¹ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅÇÔÊÑ­­Õ

 

   24.     ¾Ç.¸ÕÃÒ¾Ã

ËÅÒºàÅÔȺح

ËÑÇ˹éÒ§Ò¹ºÃÔ¡ÒèèÒ¡ÅÒ§áÅÐàǪÀѳ±ì»ÅÍ´àª×éÍ

   25.     ¾Ç.¾Ãó·Ô¾Ò

ºØ­Êè§

ËÑÇ˹éÒ§Ò¹¤Ñ´¡ÃͧáÅÐÊѧࡵÍÒ¡ÒÃ

 

   26.     ¾Ç.ÊØÇÃóÕ

ÇÃóÈÔâÃÃѵ¹ì

ËÑÇ˹éÒ§Ò¹¾ÂÒºÒÅÃѧÊÕÃÐÂÐã¡Åé

 

   27.     ¾Ç.à»ÃÁÄ´Õ

ºØ­ÀÑ·ÃÒ¹¹·ì

¾ÂÒºÒÅÇÔªÒªÕ¾ªÓ¹Ò­¡ÒÃ

 

   28.     ¾Ç.ÍÃÇÃó

àÁ×ͧÊÓÃÒ­

¾ÂÒºÒÅÇÔªÒªÕ¾ªÓ¹Ò­¡ÒÃ

 

   29.     ¾Ç.ÈÔÃÔ¾Ã

ÊǾÃÔé§

¾ÂÒºÒÅÇÔªÒªÕ¾ªÓ¹Ò­¡ÒÃ

 

   30.     ¾Ç.¸¹ÔɰÒ

ÊÓàÀҷͧ

¾ÂÒºÒÅÇÔªÒªÕ¾»¯ÔºÑµÔ¡ÒÃ

 

   31.     ¹Ò§Êءѭ­Ò

ÂѧË͡Ԩä¾ÈÒÅ

¹Ñ¡¡ÒÂÀÒ¾ºÓºÑ´»¯ÔºÑµÔ¡ÒÃ

 

   32.     ¹Ò§¹ÇŨѹ·Ãì

´Ç§¾ØÁàÁÈ

ËÑÇ˹éÒ§Ò¹¸¹Ò¤ÒÃàÅ×Í´

 

   33.     ¹Ò§ÊÒÇ»ÃÐÀÒ¾Ãó

ºÙªÒà¡ÕÂõÔ

¹Ñ¡¨Ñ´¡Òçҹ·ÑèÇä»

 

   34.     ¹Ò§ÇÃÒÀóì

ࡵØÈÃÕàÁ¦

·Õè»ÃÖ¡ÉÒ´éÒ¹¾Ñ²¹Ò¤Ø³ÀÒ¾

 

   35.     ¹Ò§ª¹Ô´Ò

ËÇѧÈÔÃÔ

·Õè»ÃÖ¡ÉÒ´éÒ¹¾Ñ²¹Ò¤Ø³ÀÒ¾

 

   36.     ¾Ç.ÇÃÒÀóì

¾Ñ¹¸ØìÍÃèÒÁ

àŢҹءÒÃÈÙ¹Âì¾Ñ²¹Ò¤Ø³ÀÒ¾

 

   37.     ¹Ò§ÊÒÇÈÂÒÁÅ

¡ÅÑè¹ÀÙÁÔÈÃÕ

¹Ñ¡¨Ñ´¡Òçҹ·ÑèÇä»

 

   38.     ¹Ò§ÊÒÇÍØÉÒ

¹Ò¤ÊØÇÃó

¹Ñ¡¨Ñ´¡Òçҹ·ÑèÇä»

 

   39.     ¹Ò§ÊÒǰҹԴÒ

·ÔÁ»ÃÐà·×ͧ

¹Ñ¡¨Ñ´¡Òçҹ·ÑèÇä»

 

 

àÃÔèÁ»ÃЪØÁ àÇÅÒ 13.30 ¹.

ÃÐàºÕºÇÒÃзÕè 1  àÃ×èͧ·Õè»Ãиҹá¨é§ãËé·Õè»ÃЪØÁ·ÃÒº 

                                            ¡ÒÃàµÃÕÂÁµÑÇà¾×èÍÃѺ Re-accreditation 3 ¨ÐàÃÔèÁÁÕ¡Òà Countdown áÅÐÁÕ¡ÒáÃеØé¹ã¹Í§¤ì¡Ã ˹éÒ§Ò¹µèÒ§ æ ·ÕÁã´·ÕèÂѧäÁèÁÕ¡ÒûÃЪØÁáÅÐÂѧäÁèä´éàµÃÕÂÁ¡ÒÃ

ËÃ×ÍÂѧäÁèÊè§¡ÒúéÒ¹ãËéÈÙ¹Âì¾Ñ²¹Ò¤Ø³ÀÒ¾ ¢ÍãËéÃÕº´Óà¹Ô¹¡Òà à¹×èͧ¨Ò¡Ê¶ÒºÑ¹Ï ÂѧÁÕ§Ò¹ãË­è·Õèµéͧ´Óà¹Ô¹¡Òà ¤×Í §Ò¹ÁË¡ÃÃÁ¤Ø³ÀÒ¾¶¹¹ÃÒªÇÔ¶Õ ¤ÃÑé§·Õè 7,  NCC14th  áÅЧҹ 50 »Õ NCI

 

                                                            ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

 

 

ÃÐàºÕºÇÒÃзÕè 2  ÃѺÃͧÃÒ§ҹ¡ÒûÃЪØÁ¤ÃÑé§·Õè 5/2561 Çѹ·Õè 16 ¡Ã¡®Ò¤Á 2561

                                            ÁµÔ·Õè»ÃЪØÁ : ÃѺÃͧÃÒ§ҹ¡ÒûÃЪØÁ â´ÂäÁèÁÕ¡ÒÃá¡éä¢

 

ÃÐàºÕºÇÒÃзÕè 3  àÃ×èͧÊ׺à¹×èͧ¨Ò¡¡ÒûÃЪØÁ¤ÃÑé§·Õè 5/2561

                                            - äÁèÁÕ -

 

ÃÐàºÕºÇÒÃзÕè 4  àÃ×èͧàʹÍà¾×è;ԨÒóÒ

                                      4.1 ÃÒ§ҹ¤ÇÒÁ¡éÒÇ˹éҢͧ¡ÅØèÁ§Ò¹¾Ñ²¹Ò¤Ø³ÀÒ¾ (ÃÒÂÅÐàÍÕ´µÒÁ Slide Present)

                                      - ÃÒ§ҹ¤ÇÒÁ¡éÒÇ˹éÒ㹡ÒèѴ·ÓẺ»ÃÐàÁÔ¹Êè§ Êþ.

                                                      ÃÒ§ҹâ´Â ¹ÒÂá¾·ÂìÊÁªÒ ¸¹ÐÊÔ·¸ÔªÑ ¼ÙéªèǼÙéÍӹǡÒôéÒ¹¾Ñ²¹Ò¤Ø³ÀÒ¾âç¾ÂÒºÒÅ áÅÐÃÑ¡ÉÒ¡ÒÃËÑÇ˹éÒ¡ÅØèÁ§Ò¹¾Ñ²¹Ò¤Ø³ÀÒ¾

 

¢éÍàʹÍá¹Ð

»Ãиҹ : ¢ÍãËé·Ø¡·ÕÁ·º·Ç¹¤Ø³ÀÒ¾¡ÒôÙáżÙé»èǨҡàǪÃÐàºÕ¹ áÅÐàµÃÕÂÁ¤ÇÒÁ¾ÃéÍÁ˹éÒ§Ò¹

 

                                                            ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

 

                                      4.2 ·ÕÁ¾Ñ²¹Ò¤Ø³ÀÒ¾

                                    -  µÑǪÕéÇÑ´¢Í§·ÕÁ »Õ 2561 (µ.¤. 60 - ÁÔ.Â. 61)

                                    -  Risk Profile

 

                                                4.2.1 ·ÕÁ¾Ñ²¹Ò¤Ø³ÀÒ¾¼Ùé»èǹ͡ (SLT OPD)(ÃÒÂÅÐàÍÕ´µÒÁ Slide Present)

                                                                ÃÒ§ҹâ´Â ¹ÒÂá¾·Âì»ÔÂÇѲ¹ì  àÅÒÇËØµÒ¹¹·ì »Ãиҹ·ÕÁ

¢éÍàʹÍá¹Ð

»Ãиҹ : ·ÕÁµéͧ¹ÓàÊ¹Í Flow ÍѹãËÁè ¤ÇÒÁÅèÒªéÒã¹àÇÅÒ·ÕèÃͤ͵ÒÁ·Õè·ÕÁºÍ¡ àË繪ѴÇèÒ Follow up àÃçÇ¡ÇèÒÃÐÂÐàÇÅÒÃͤÍ à¾×èÍãËé¼ÙéàÂÕèÂÁàË繪ѴÇèÒÃÐÂÐàÇÅÒÃͤÍÂàÃÒÁÕ¡ÒûÃѺ»Ãا¨ÃÔ§

Í.ÇÃÒÀóì : Flow ¢Í§·ÕÁÂѧäÁè¡ÃЪѺ ÃÐÂÐàÇÅÒ·ÕÁ·ÃÒºËÃ×ÍäÁèÇèÒÍÂÙè step ä˹ áÅÐ Trend ¢Í§Êþ.  ¨ÐÁÕ¡ÒÃàÃÕ¡ CPR á¹è¹Í¹ µÍ¹¹Õé¢Í§ OPD ¡ÓÅѧ¨ÐàµÃÕÂÁ«éÍÁÍÂÙè ¢ÍãËéÅÍ§ÊØèÁ·´Êͺ à¾×èͨÐä´éàËç¹âÍ¡ÒÊ¡ÒþѲ¹Ò

                                                                               

                                                            ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

 

                                                                         4.2.2  ·ÕÁ PCT ÈÑÅ¡ÃÃÁ  (ÃÒÂÅÐàÍÕ´µÒÁ Slide Present)

                                                                ÃÒ§ҹâ´Â ¹ÒÂá¾·Â촹ѠÁâ¹ÃÁ³ì »Ãиҹ·ÕÁ

¢éÍàʹÍá¹Ð

¹ÒÂá¾·ÂìÊÁªÒ ¸¹ÐÊÔ·¸ÔªÑ : 1. KPI áÅÐ Process µéͧÊÍ´¤Åéͧ¡ÑºÊÔè§·ÕèàÃÒàÍÒÁÒ show

                                                            2. ÁÕ¡Òý֡ͺÃÁà¤Ã×èͧÁ×ÍãËÁè ÊÓËÃѺᾷÂìáÅоÂÒºÒÅËÃ×ÍäÁè ¤ÇÃà¡çº¢éÍÁÙÅäÇé

                                                            3. ¡µÑÇÍÂèÒ§ã¹¡ÅØèÁ·ÕèãËéÂÒà¤ÁպӺѴÁÒ¡è͹ ÁÒÃѺ¡ÒÃÃÑ¡ÉÒ·Ò§ÈÑÅ¡ÃÃÁ

                                                                  ÁÕ¡ÒûÃÐàÁÔ¹ËÃ×ÍäÁèÇèÒ¤¹ä¢é ÁÕ Complication ËÃ×ÍäÁè

                                                            4. á¼¹¼èҵѴµèÍà¹×èͧ

 

                                                                                ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

 

                                               4.2.3 ·ÕÁ PCT ÃѧÊÕÃÑ¡ÉÒ (ÃÒÂÅÐàÍÕ´µÒÁ Slide Present)

                                                                ÃÒ§ҹâ´Â ¹ÒÂá¾·Âì¾ÕÃÇÔª­ì  ·Ñ¾Ç§Éì »Ãиҹ·ÕÁ

¢éÍàʹÍá¹Ð

¹ÒÂá¾·ÂìÊÁªÒ ¸¹ÐÊÔ·¸ÔªÑ : 1. Slide ¹ÓàʹͤÇûÃѺ¢¹Ò´µÑÇ˹ѧÊ×ÍáÅÐÊÕ  

                                                            2. äÁè¤Çþٴ¶Ö§ã¹àÃ×èͧ Physical Dropout

                                                            3. ¤ÇÒÁàÊÕ觢ͧ¼Ùé»èÇ áÅкؤÅÒ¡ÃÁÕ¡ÒõÃÇ¨ÊØ¢ÀÒ¾à»ç¹ÍÂèÒ§äÃ

                                                            4. ¡ÒèѴ¡ÒÃã¹àÃ×èͧ Continue of care à¡Ô´¢Öé¹áÅéÇ ÁÕ¡ÒèѴ¡ÒÃÍÂèÒ§äÃ

                                                            5. Treatment dropout Áͧàª×èÍÁâ§à»ç¹ÍÂèÒ§äÃ

»Ãиҹ :  Case ÃÐÂÐàÇÅÒÃͤÍÂà¡Ô¹ 6 Week ¢Í§ RT à»ç¹¡ÅØèÁä˹ áÅлѭËÒÍÂÙèµÃ§ä˹ ÁÕ¡Ãкǹ¡ÒÃá¡éä¢ÍÂèÒ§äÃ

                     

                                                                                ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

 

                                                4.2.4 ·ÕÁ»éͧ¡Ñ¹áÅФǺ¤ØÁ¡ÒõԴàª×éÍ.ppt·ÕÁ PCT à¤ÁպӺѴ (ÃÒÂÅÐàÍÕ´µÒÁ Slide Present)

                                                                ÃÒ§ҹâ´Â ¾Ç.ÇÔÅÒÇÑÅÂì  àÅéÒÊ¡ØÅ  àŢҹءÒ÷ÕÁ

¢éÍàʹÍá¹Ð

¹ÒÂá¾·ÂìÊÁªÒ ¸¹ÐÊÔ·¸ÔªÑ : 1. ¢éÍÁÙŵÑǪÕéÇÑ´·ÕèÂѧäÁè¤Ãº áÅТÍãËé·ÕÁÃպ任ÃѺãËéà»ç¹»Ñ¨¨ØºÑ¹

                                                            2. ¼Ùé»èÇÂà¤ÁպӺѴ·Õè Refer ÁÒ ÃÐÂÐàÇÅÒÃͤÍÂà¡Ô¹ 6 ÊÑ»´ÒËìÁÒ¡¢Öé¹

                                                                 ¢ÍãËé·ÕÁÇÔà¤ÃÒÐËì¢éÍÁÙÅ

                                                            3. ¢ÍãËé·ÕÁ¨Ñ´·Ó Risk Profile

 

                                                                                ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

 

                                                4.2.5 ·ÕÁ ECT Uro (ÃÒÂÅÐàÍÕ´µÒÁ Slide Present)

                                                                ÃÒ§ҹâ´Â ¹ÒÂá¾·ÂìÈØÀÇѲ¹ì  ÈÔÃԤػµì  »Ãиҹ·ÕÁ

¢éÍàʹÍá¹Ð

¹ÒÂá¾·ÂìÊÁªÒ ¸¹ÐÊÔ·¸ÔªÑ : ¡ÅØèÁ¼Ùé»èÇ·Õèà»ç¹ CA Prostate ÍÂèÒ§à´ÕÂÇ áÅÐ¡ÅØèÁ¤¹ä¢é·Õèà»ç¹ CA Bladder ·ÕèãªéÂÒà¤ÁպӺѴ·ÓÍÂèÒ§äÃ

 

                                                                                ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

 

                                                4.2.6 ·ÕÁ ECT Gastrointestinal  (ÃÒÂÅÐàÍÕ´µÒÁ Slide Present)

                                                                ÃÒ§ҹâ´Â ¾Ç.ÈØÀÒÃÁÂì ÈÃըѹ·Ãì´Õ  àŢҹءÒ÷ÕÁ

¢éÍàʹÍá¹Ð

¹ÒÂá¾·ÂìÊÁªÒ ¸¹ÐÊÔ·¸ÔªÑ : 1. ¢éÍÁÙÅ KPI ¢Í§·ÕÁµÑÇä˹·ÕèµéͧÇÔà¤ÃÒÐËì µéͧá»Å¢éÍÁÙÅãËéà¡Ô´¤ÇÒÁËÁÒÂ

                                                        2. Flow ¢Í§·ÕÁ·ÕèÁÕ Complication µéͧ´Ù·Ñé§ËÁ´

 

                                                                                ÁµÔ·Õè»ÃЪØÁ : ÃѺ·ÃÒº

ÃÐàºÕºÇÒÃзÕè 5 àÃ×èͧÍ×è¹ æ

                                         - äÁèÁÕ -

 

àÅÔ¡»ÃЪØÁ àÇÅÒ 17.00 ¹.

                 

 

 

(¹Ò§ÊÒÇÈÂÒÁÅ  ¡ÅÑè¹ÀÙÁÔÈÃÕ)

¹Ñ¡¨Ñ´¡Òçҹ·ÑèÇä»

¼Ùé¨Ñ´·ÓÃÒ§ҹ¡ÒûÃЪØÁ  

 

               

 

 (¹Ò§ÊÒÇÇÃÒÀÃ³ì  ¾Ñ¹¸ØìÍÃèÒÁ)

¾ÂÒºÒÅÇÔªÒªÕ¾ªÓ¹Ò­¡ÒÃ

¼Ù騴ÃÒ§ҹ¡ÒûÃЪØÁ

                            

 

      

 (¹Ò§¨ÔÃѹ´Ò  ä¡ÃÄ·¸ÔªÑÂ)

¹Ñ¡ÇÔªÒ¡ÒÃÊÒ¸ÒÃ³ÊØ¢ªÓ¹Ò­¡ÒÃ

¼ÙéµÃǨÃÒ§ҹ¡ÒûÃЪØÁ

                            

                

                                            

 (¹ÒÂÊÁªÒ ¸¹ÐÊÔ·¸ÔªÑÂ)

¹ÒÂá¾·ÂìªÓ¹Ò­¡ÒþÔàÈÉ

¼ÙéÃѺÃͧÃÒ§ҹ¡ÒûÃЪØÁ